Tegretol (brand name for Carbamazepine) falls in the category of prescription medication and is an anticonvulsant and specific analgesic that helps reduce and control epileptic seizures. Also, the product is effective in trigeminal neuralgia, a disorder manifested through intense pain in the face area, originating in the trigeminal nerve.
The manufacturer claims the exact mechanism of action of the drug remains unknown. Controlled clinical tests have proven the product effective in the treatment of psychomotor and grand mal seizures, as well as trigeminal neuralgia.
The manufacturing company is Novartis, a business which currently operates in 140 countries and is based in Basel, Switzerland. Novartis is a worldwide reputable company, with a global Pharmaceuticals portfolio including more than 60 key marketed products, marketed under several brands.
Tagretol is a form of prescription medication, therefore it should not be administrated if not prescribed by a doctor.
Tegretol (tablets) includes the following ingredients: Carbamazepine (active ingredient), Colloidal silicon dioxide, D&C Red No. 30 Aluminum Lake (chewable tablets only), FD&C Red No. 40 (200-mg tablets only), flavoring (chewable tablets only), gelatin, glycerin, magnesium stearate, sodium starch glycolate (chewable tablets only), starch, stearic acid, and sucrose (chewable tablets only).
Tegretol is indicated for use as an anticonvulsant drug. Drug controlled studies have been conducted to prove its effectiveness in patients with partial seizures, generalized tonic-clonic seizures (known as grand mal) or mixed seizures. Absence seizures (or petit mal) do not appear to be controlled by Tagretol.
Contraindications include patients with a history of previous bone marrow depression, hypersensitivity to the drug or known sensitivity to any of the compounds, or patients who are under treatment with monoamine oxidase inhibitors (MAO inhibitors).
Tagretol side effects are rare, but serious and may include skin rashes, sores in the mouth, hives, blistering or peeling of the skin, severe fatigue, easy bruising, bleeding gums or nose bleeds, suicidal thoughts, irritability or panic attacks.
Dosage is established by the physician and depends on the disorder the product is used for, age of the patient and severity of the condition.
- Existing clinical trials which prove product effectiveness
- The manufacturer is a worldwide renowned company
- No evidence of potential abuse has been associated with the drug, nor is there evidence of psychological or physical dependence in humans
- Positive consumer reviews.
- The product has a number of harmful side effects associated
- There is a list of warnings, precautions and contraindications associated.
Tagretol is the brand name under which Carbamazepine is sold by Novartis. This is a prescription medicine used to treat certain types of seizures (partial, tonic-clonic or mixed) and certain types of nerve pain (such as trigeminal neuralgia). This is not however a regular pain medicine and should not be used for aches or pains, and, like any prescription drug, has been associated with a list of potentially harmful side effects.
Tagretol consumer reviews are generally positive, reporting great results in controlling epilepsy and seizures, trigeminal neuralgia, depression and even bipolar disorder or MS (multiple sclerosis).
The drug should be used on medical prescription and only after a thorough examination and evaluation of the patient.